As I had mentioned in the notes above the first video on Oct 15th, unfortunately, there isn’t an ETF that provides a one-and-done way to go long the Generic & Specialty Drug sub-sector. Hence, the reason for the ‘shotgun’ approach.

However, if you revisit that video and/or any of the follow-up posts/video since (which can be viewed here: https://rightsideofthechart.com/tag/coll/ ) I think you will find that on collectively, of those stocks that were first highlighted in the original video of the sector on Oct 15th that either were mentioned as already offering an objective long entry at that time -OR- went on to trigger an objective long entry via the pre-determined criteria since that video (many of those 3 dozen stocks were only untriggered trade setups), collectively those actionable trades have posted very nice returns, probably easily into the double-digits on average.

When I come across a sector in which the majority of the components stand out as bullish or bearish, I will often add the sector ETF as an official trade idea (e.g.- GDX, SOXX, etc.) along with highlighting the best looking individual stocks. When there isn’t a ETF that specific targets that sector or the sector ETF might not hold a lot of the standout stocks that I like (such as the SEA & the shipping stocks that I highlighted as longs about a month ago), then I suggest the shotgun approach.

I believe Randy wanted us to take a “shotgun” approach to this group of stocks for diversification. This one certainly took off, but I would consider this a grand slam if the other pellets go in the same direction. Time will tell.

I saw your previous post on COLL. I thought you were one of fews who took this trade and booked the profits. I saw the video regarding 37 stocks the other day. If COLL were an official trade, it would be a grand slam for many. Still Very impressive!